SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form S-3 - Registration statement under Securities Act of 1933:
SEC Accession No. 0001144204-17-063542
Filing Date
2017-12-13
Accepted
2017-12-13 17:19:46
Documents
5

Document Format Files

Seq Description Document Type Size
1 FORM S-3 tv481252_s3.htm S-3 172909
2 EXHIBIT 5.1 tv481252_ex5-1.htm EX-5.1 22375
3 EXHIBIT 23.2 tv481252_ex23-2.htm EX-23.2 2894
4 GRAPHIC apks_logo1.jpg GRAPHIC 19213
5 GRAPHIC apks_logo2.jpg GRAPHIC 6429
  Complete submission text file 0001144204-17-063542.txt   234867
Mailing Address 9620 MEDICAL CENTER DR STE 300 ROCKVILLE MD 20850
Business Address 9620 MEDICAL CENTER DR STE 300 ROCKVILLE MD 20850 240-864-2600
CASI Pharmaceuticals, Inc. (Filer) CIK: 0000895051 (see all company filings)

IRS No.: 581959440 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-3 | Act: 33 | File No.: 333-222046 | Film No.: 171254610
SIC: 2836 Biological Products, (No Diagnostic Substances)